STOCK TITAN

Johnson & Johnson to Participate in the 2024 Wells Fargo Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Johnson & Johnson (NYSE: JNJ) has announced its participation in the 2024 Wells Fargo Healthcare Conference on Thursday, September 5th, at the Encore Boston Harbor, Evertte, MA. Tim Schmid, Executive Vice President and WorldWide Chairman of MedTech, will represent the company in a session scheduled for 11:00 am (Eastern Time).

The event will feature a live audio webcast accessible to investors and interested parties through the Johnson & Johnson website at www.investor.jnj.com. An audio replay will be available approximately 48 hours after the webcast concludes. This conference provides an opportunity for JNJ to showcase its latest developments and strategies in the healthcare sector.

Johnson & Johnson (NYSE: JNJ) ha annunciato la sua partecipazione alla Conferenza sulla Salute Wells Fargo 2024 che si terrà giovedì 5 settembre, presso l'Encore Boston Harbor, Everett, MA. Tim Schmid, Vice Presidente Esecutivo e Presidente Mondiale di MedTech, rappresenterà l'azienda in una sessione programmata per le 11:00 (Eastern Time).

L'evento includerà un webcast audio dal vivo accessibile a investitori e parti interessate tramite il sito web di Johnson & Johnson su www.investor.jnj.com. Una registrazione audio sarà disponibile circa 48 ore dopo la conclusione del webcast. Questa conferenza offre a JNJ l'opportunità di presentare i suoi ultimi sviluppi e strategie nel settore sanitario.

Johnson & Johnson (NYSE: JNJ) ha anunciado su participación en la Conferencia de Salud Wells Fargo 2024 que se llevará a cabo el jueves 5 de septiembre en el Encore Boston Harbor, Everett, MA. Tim Schmid, Vicepresidente Ejecutivo y Presidente Mundial de MedTech, representará a la empresa en una sesión programada para las 11:00 am (Hora del Este).

El evento incluirá un webcast de audio en vivo accesible para inversionistas y partes interesadas a través del sitio web de Johnson & Johnson en www.investor.jnj.com. Se dispondrá de una grabación de audio aproximadamente 48 horas después de que concluya el webcast. Esta conferencia ofrece a JNJ la oportunidad de mostrar sus últimos desarrollos y estrategias en el sector salud.

존슨 앤 존슨 (NYSE: JNJ)은 2024 웰스 파고 헬스케어 컨퍼런스에 참여할 것이라고 발표했습니다. 이번 컨퍼런스는 9월 5일 목요일에 매사추세츠주 에버렛의 앙코르 보스턴 하버에서 열립니다. 팀 슈미드, 집행 부사장 겸 세계 MedTech 의장, 이 회사의 대표로 동부 표준시 기준 오전 11시 세션에 참석할 예정입니다.

이번 행사에서는 투자자와 이해관계자가 www.investor.jnj.com를 통해 접속할 수 있는 실시간 오디오 웹캐스트가 진행됩니다. 웹캐스트 종료 후 약 48시간 후에는 오디오 재생을 이용할 수 있습니다. 이번 컨퍼런스는 JNJ가 헬스케어 분야의 최신 개발 사항과 전략을 선보일 수 있는 기회를 제공합니다.

Johnson & Johnson (NYSE: JNJ) a annoncé sa participation à la Conférence sur la Santé Wells Fargo 2024 qui se tiendra le jeudi 5 septembre à l'Encore Boston Harbor, Everett, MA. Tim Schmid, Vice-président exécutif et président mondial de MedTech, représentera l'entreprise lors d'une session prévue à 11h00 (heure de l'Est).

L'événement comportera un webcast audio en direct accessible aux investisseurs et aux parties intéressées via le site web de Johnson & Johnson à www.investor.jnj.com. Une rediffusion audio sera disponible environ 48 heures après la fin du webcast. Cette conférence offre à JNJ l'occasion de présenter ses derniers développements et stratégies dans le secteur de la santé.

Johnson & Johnson (NYSE: JNJ) hat seine Teilnahme an der 2024 Wells Fargo Healthcare Conference angekündigt, die am Donnerstag, den 5. September, im Encore Boston Harbor, Everett, MA, stattfindet. Tim Schmid, Executive Vice President und Worldwide Chairman von MedTech, wird das Unternehmen in einer Sitzung vertreten, die für 11:00 Uhr (Eastern Time) angesetzt ist.

Die Veranstaltung wird einen live Audio-Webcast umfassen, der für Investoren und Interessierte über die Website von Johnson & Johnson unter www.investor.jnj.com zugänglich ist. Eine Audio-Aufzeichnung wird etwa 48 Stunden nach dem Ende des Webcasts verfügbar sein. Diese Konferenz bietet JNJ die Möglichkeit, seine neuesten Entwicklungen und Strategien im Gesundheitswesen zu präsentieren.

Positive
  • None.
Negative
  • None.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will participate in the 2024 Wells Fargo Healthcare Conference on Thursday, September 5th, at the Encore Boston Harbor, Evertte, MA. Tim Schmid, Executive Vice President, WorldWide Chairman, MedTech will represent the Company in a session scheduled at 11:00 am (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

Media contact:

media-relations@its.jnj.com



Investor contact:

investor-relations@its.jnj.com

Source: Johnson & Johnson

FAQ

When is Johnson & Johnson (JNJ) participating in the 2024 Wells Fargo Healthcare Conference?

Johnson & Johnson (JNJ) is participating in the 2024 Wells Fargo Healthcare Conference on Thursday, September 5th.

Who will represent Johnson & Johnson (JNJ) at the 2024 Wells Fargo Healthcare Conference?

Tim Schmid, Executive Vice President and WorldWide Chairman of MedTech, will represent Johnson & Johnson (JNJ) at the conference.

What time is Johnson & Johnson's (JNJ) session at the 2024 Wells Fargo Healthcare Conference?

Johnson & Johnson's (JNJ) session is scheduled for 11:00 am Eastern Time on September 5th, 2024.

Where can investors access the live audio webcast of Johnson & Johnson's (JNJ) conference session?

Investors can access the live audio webcast through Johnson & Johnson's website at www.investor.jnj.com.

How long after the webcast will the audio replay be available for Johnson & Johnson's (JNJ) conference session?

The audio replay of Johnson & Johnson's (JNJ) conference session will be available approximately 48 hours after the webcast.

Johnson & Johnson

NYSE:JNJ

JNJ Rankings

JNJ Latest News

JNJ Stock Data

353.35B
2.41B
0.09%
72.76%
0.78%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NEW BRUNSWICK